Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. Ventak CHF Investigators.

Higgins SL, Yong P, Sheck D, McDaniel M, Bollinger F, Vadecha M, Desai S, Meyer DB.

J Am Coll Cardiol. 2000 Sep;36(3):824-7.

2.

Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. The VIGOR CHF and VENTAK CHF Investigators.

Saxon LA, Boehmer JP, Hummel J, Kacet S, De Marco T, Naccarelli G, Daoud E.

Am J Cardiol. 1999 Mar 11;83(5B):120D-123D. Review.

PMID:
10089853
3.

Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia.

Stellbrink C, Auricchio A, Diem B, Breithardt OA, Kloss M, Schöndube FA, Klein H, Messmer BJ, Hanrath P.

Am J Cardiol. 1999 Mar 11;83(5B):143D-150D.

PMID:
10089857
4.

Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy.

Kühlkamp V; InSync 7272 ICD World Wide Investigators..

J Am Coll Cardiol. 2002 Mar 6;39(5):790-7.

5.

Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.

Desai AD, Burke MC, Hong TE, Kim S, Salem Y, Yong PG, Knight BP.

J Cardiovasc Electrophysiol. 2006 May;17(5):486-90.

PMID:
16684019
6.

Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.

Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, Sharma A; Dual Chamber and VVI Implantable Defibrillator Trial Investigators..

JAMA. 2002 Dec 25;288(24):3115-23.

PMID:
12495391
7.

The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.

Wilkoff BL; Dual Chamber and VVI Implantable Defibrillator trial investigators..

Card Electrophysiol Rev. 2003 Dec;7(4):468-72.

PMID:
15071277
8.

Eligibility for biventricular pacing in patients with an implantable cardioverter defibrillator.

Molhoek SG, Bax JJ, van Erven L, Steendijk P, van der Wall EE, Schalij MJ.

Eur J Heart Fail. 2003 Jun;5(3):315-7.

9.

Impact of biventricular pacing on mortality in a randomized crossover study of patients with heart failure and ventricular arrhythmias.

Lozano I, Bocchiardo M, Achtelik M, Gaita F, Trappe HJ, Daoud E, Hummel J, Duby C, Yong P; VENTAK CHF/CONTAK CD Investigators Study Group..

Pacing Clin Electrophysiol. 2000 Nov;23(11 Pt 2):1711-2.

PMID:
11139906
10.

Biventricular pacing improves quality of life and exercise tolerance in patients with heart failure and intraventricular conduction delay.

Krahn AD, Snell L, Yee R, Finan J, Skanes AC, Klein GJ.

Can J Cardiol. 2002 Apr;18(4):380-7.

PMID:
11992131
11.

Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study.

Boriani G, Müller CP, Seidl KH, Grove R, Vogt J, Danschel W, Schuchert A, Djiane P, Biffi M, Becker T, Bailleul C, Trappe HJ; Resynchronization for the HemodYnamic Treatment for Heart Failure Management II Investigators..

Am Heart J. 2006 May;151(5):1050-8.

PMID:
16644335
12.

[Indications and potential benefits of implantable automatic defibrillator endowed with biventricular pacing].

Ansalone G, Ricci R, Cacciatore G, Santini M.

Ital Heart J Suppl. 2001 Dec;2(12):1308-14. Italian.

PMID:
11838353
13.

Intermediate-term results of biventricular pacing in heart failure: correlation between clinical and hemodynamic data.

Reuter S, Garrigue S, Bordachar P, Hocini M, Jaïs P, Haïssaguerre M, Clementy J.

Pacing Clin Electrophysiol. 2000 Nov;23(11 Pt 2):1713-7.

PMID:
11139907
14.

Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.

Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K; Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators..

JAMA. 2003 May 28;289(20):2685-94.

PMID:
12771115
15.

Should stimulation therapy for congestive heart failure be combined with defibrillation backup?

Gaita F, Bocchiardo M, Porciani MC, Vivalda L, Colella A, Di Donna P, Caponi D, Bruzzone M, Padeletti L.

Am J Cardiol. 2000 Nov 2;86(9A):165K-158K.

PMID:
11084118
16.

Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias.

Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, Boehmer JP, Higginbotham MB, De Marco T, Foster E, Yong PG.

J Am Coll Cardiol. 2003 Oct 15;42(8):1454-9.

17.

Conversion rates of induced versus spontaneous ventricular tachycardia by a third generation cardioverter defibrillator. The VENTAK PRx Phase I Investigators.

Porterfield JG, Porterfield LM, Smith BA, Bray L, Voshage L, Martinez A.

Pacing Clin Electrophysiol. 1993 Jan;16(1 Pt 2):170-3.

PMID:
7681566
18.
19.
20.

Inappropriate shock delivery due to ventricular double detection with a biventricular pacing implantable cardioverter defibrillator.

Schreieck J, Zrenner B, Kolb C, Ndrepepa G, Schmitt C.

Pacing Clin Electrophysiol. 2001 Jul;24(7):1154-7.

PMID:
11475833

Supplemental Content

Support Center